LYRA
Lyra Therapeutics Inc
NASDAQ: LYRA · HEALTHCARE · BIOTECHNOLOGY
$0.71
+0.00% today
Updated 2026-04-30
Market cap
$870050.00
P/E ratio
—
P/S ratio
1.45x
EPS (TTM)
$-22.90
Dividend yield
—
52W range
$0 – $34
Volume
0.1M
Lyra Therapeutics Inc (LYRA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-101.1%
Last 4 quarters
Revenue YoY growth
-87.2%
Most recent quarter
EPS YoY growth
-2340.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-9.9%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-9.9%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-12 | $-3.38 | -1727.0% | $4.24 | $3.82 | -9.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $-0.19 | $-3.38 | -1727.0% | $25000.00 | -87.2% |
| 2025-06-30 | $-0.17 | $-5.22 | -3063.3% | $183000.00 | -69.4% |
| 2025-03-31 | $-0.14 | $-0.13 | +4.9% | $183000.00 | -65.6% |
| 2024-12-31 | $-0.13 | $-0.14 | -9.2% | $209000.00 | +43.2% |
| 2024-09-30 | $-0.21 | $-0.14 | +32.4% | $195000.00 | -64.2% |
| 2024-06-30 | $-0.33 | $-0.74 | -124.2% | $598000.00 | +30.6% |
| 2024-03-31 | $-0.26 | $-0.35 | -34.6% | $532000.00 | +29.8% |
| 2023-12-31 | $-0.31 | $-0.22 | +29.0% | $146000.00 | +1227.3% |
| 2023-09-30 | $-0.32 | $-0.27 | +15.6% | $544000.00 | — |
| 2023-06-30 | $-0.42 | $-0.32 | +23.8% | $458000.00 | — |
| 2023-03-31 | $-0.36 | $-0.44 | -22.2% | $410000.00 | — |
| 2022-12-31 | $-0.41 | $-0.38 | +7.3% | $11000.00 | — |
Frequently asked questions
Has Lyra Therapeutics Inc beaten earnings estimates?
Lyra Therapeutics Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -101.1% over the last 4 quarters.
How does LYRA stock react to earnings?
LYRA stock has moved an average of -9.9% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.
What is Lyra Therapeutics Inc's revenue growth rate?
Lyra Therapeutics Inc reported year-over-year revenue growth of -87.2% in its most recent quarter, with EPS growing -2340.4% year-over-year.